Lucid Diagnostics (LUCD)

Lucid Diagnostics (LUCD) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• LUCD last traded at $0.42, 7.64% on the day.
• Lucid Diagnostics: P/E -0.8, revenue $5.45M over the last four quarters.
• Over the past year LUCD returned -61.48%; year to date -61.48%.

Updated 2026-11-06 11:46 UTC